Aquapharm Biodiscovery Ltd., a UK-based marine biotech company, has raised Gbp4 million in second-round funding. Aescap Venture led the deal with a Gbp1.5 million infusion, and was joined by Tate & Lyle Ventures and return backers Scottish Enterprise, NESTA Investments and HIE Argyll and the
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.